Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
7.20
-0.08 (-1.08%)
At close: Aug 22, 2025, 4:00 PM
7.20
0.00 (-0.02%)
After-hours: Aug 22, 2025, 5:58 PM EDT
Quoin Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Quoin Pharmaceuticals.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Quoin Pharmaceuticals.
Recommendation Trends
| Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $525 → $140 | Strong Buy | Maintains | $525 → $140 | +1,844.07% | Mar 15, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8,400 | Strong Buy | Initiates | $8,400 | +116,543.99% | Sep 7, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10,500 | Strong Buy | Initiates | $10,500 | +145,704.98% | May 6, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $26,250 | Strong Buy | Initiates | $26,250 | +364,412.46% | Jan 7, 2022 |
| JMP Securities | JMP Securities | Buy Initiates $42,000 | Buy | Initiates | $42,000 | +583,119.93% | Dec 15, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.66M
EPS This Year
-30.82
from -66.90
EPS Next Year
-14.28
from -30.82
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 13.7M | 103.0M | ||
| Avg | n/a | 6.7M | 58.1M | ||
| Low | n/a | n/a | 15.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,446.3% | ||
| Avg | - | - | 772.8% | ||
| Low | - | - | 133.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -18.38 | -12.86 | 29.40 |
| Avg | -30.82 | -14.28 | 13.03 |
| Low | -44.93 | -15.44 | -2.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.